CASP1 and acute lymphoblastic leukemia: Upregulation and serving as a prognostic biomarker in acute lymphoblastic leukemia (ALL) [106], and regulating gefitinib resistance in lung adenocarcinoma cells through interactions with miR-377/CASP1 axis [111] are other recent discovered activities of SGHG5.